Adage Capital Partners Gp, L.L.C. Assembly Biosciences, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$10.27 - $21.23 $795,873 - $1.65 Million	-77,495 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$8.36 - $23.81 $647,858 - $1.85 Million	77,495 New	77,495 $1.59 Million
Q2 2019 Aug 14, 2019	SELL	$12.9 - $20.8 $967,500 - $1.56 Million	-75,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$34.41 - $44.23 $4.3 Million - $5.53 Million	-125,000 Reduced 62.5%	75,000 $2.79 Million
Q2 2018 Aug 14, 2018	BUY	$39.21 - $50.29 $980,250 - $1.26 Million	25,000 Added 14.29%	200,000 $7.84 Million
Q4 2017 Feb 14, 2018	BUY	$28.58 - $49.91 $5 Million - $8.73 Million	175,000	175,000 $7.92 Million

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.